Entering text into the input field will update the search result below

July 06 2020 – Top Medical Stocks To Watch This Week

Jul. 06, 2020 8:27 PM ETTeladoc Health, Inc. (TDOC), DXCM, VRTX, WST, SGEN
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Long/Short Equity, Special Situations, Growth, Growth At A Reasonable Price

Seeking Alpha Analyst Since 2007

Michael Michaud is the founder owner of Invest2Success.com (http://www.invest2success.com/). He has been investing and trading in the financial markets since 1989.

He founded Invest2Success.com to empower independent and institutional investors traders to take control of their financial destiny by providing them education training mentorship and support for them to research analyze invest and trade in the markets successfully in the long-term.

As he says, "With knowledge, dated goals, a plan of action, then taking action, profitable investing and trading success will only be a matter of time."

Summary

  • Teladoc Dexcom Lead Five Medical Stocks In Or Near Buy Zones.

July 06 2020 – Top Medical Stocks To Watch This Week

Go To July 06 2020 - Top Medical Stocks To Watch This Week

Stock Investment Advisory

Invest2Success

Stock Investing Trading Coaching

Coaching

$TDOC #Teledoc $DXCM #Dexcom $VRTX #Vertex $WST #WestPharmaceuticals $SGEN #SeattleGenetic #coronavirus #medical #healthcare #stocks #stockstowatch #stockmarket #wallstreet #nyse #sp500 #investing #investors #trading #traders #elliottwave #markets #finance #economy #technology #financialforecast

Analyst's Disclosure: I am/we are long TDOC.

Invest2Success Stock Investment Advisory Service - http://www.invest2success.com/

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.